It appears that your browser has JavaScript disabled.

This Website requires your browser to be JavaScript enabled.

Please enable JavaScript and reload this page.

merk

457 Results Advanced Search

Press Release: Merck Receives Two More Patents for CRISPR Technology
Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck's patent applications for the company's CRISPR technology.
Strengthening our US Presence | About Us | Merck
Merck KGaA, Darmstadt, Germany is investing $115 million in a new life science campus in the Boston area, one of the most important science and technology hubs in the world.
Press Release: Merck Expands Popular Line of Guava® Flow Cytometers
Merck is expanding its popular line of Guava® flow cytometers to include a high-power modulated green laser.
Press Release: Merck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers
Merck today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers.
Press Release: Merck Intends to Launch Innovative System for Monitoring CD4 T lymphocytes and T cells throughout Africa
Merck today hosted a discussion with renowned researchers to discuss the intention to launch its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts throughout Africa.
Press Release: Merck to Supply Single-use Systems to WuXi Biologics for Non-GMP Pilot Plant in Shanghai
Merck was selected by contract development and manufacturing organization WuXi Biologics to provide Merck's Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China.
Press Release: Merck Completes Third and Final Registration Phase under the European Chemicals Regulation REACH
Merck today announced that it has successfully submitted a total of more than 1,000 registration dossiers under the European chemicals regulation REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) by the end of the third and final registration deadline of May 31, 2018.
Press Release: Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children
Merck, a leading science and technology company and leader in genome editing, today announced a collaboration with Washington University in St. Louis, Missouri, USA, that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome).
Labiotech June | Emerging Biotech | Merck
Merck sponsors the Refresh's Startup battle at Labiotech, Berlin on June 8, 2017
Merck Life Science Center | Merck
Merck KGaA, Darmstadt, Germany is proud to announce the opening of a new life science center in Burlington, Massachusetts - a major global hub for collaboration with partners and customers.